日本の臨床化学・免疫診断市場

調査会社Venture Planning Group社が発行したリサーチレポート(データ管理コード:VPCC8135)
◆英語タイトル:New Frontiers in the Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
◆発行会社/調査会社:Venture Planning Group
◆商品コード:VPCC8135
◆発行日:2014年5月
◆調査対象地域:日本
◆ページ数:※レポート概要をご参照ください。
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Local LicenseUSD7,600 ⇒換算¥858,800見積依頼/購入/質問フォーム
Global LicenseUSD16,700 ⇒換算¥1,887,100見積依頼/購入/質問フォーム
DataPackUSD4,900 ⇒換算¥553,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[日本の臨床化学・免疫診断市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900.

New Frontiers in the Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study of the major business opportunities emerging in the Japanese clinical chemistry and immunodiagnostic markets during the next five years.  The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Japan Market Overview

- Estimates of facilities performing clinical chemistry
and immunodiagnostic tests.

- Test volume and sales projections.

Strategic Recommendations

- New product development opportunities
with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Market Segmentation Analysis

- Comprehensive review of the market
dynamics, trends, structure, size, growth,
and key suppliers.

- Test volume and sales forecasts for over 100 clinical chemistry,
TDM, endocrine, cancer, immunoprotein and abused drug assays,
by market segment:
    
     ° Hospitals
     ° Commercial/Private Laboratories

Tests Analyzed in the Report

[u]Routine Clinical Chemistry [/u]

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total,
BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

[u]Therapeutic Drug Monitoring (TDM) [/u]

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,
Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,
Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

[u]Endocrine Function[/u]

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,
Prolactin, T3, T3 Uptake,  Free T3, T4, Free T4, TBG, Testosterone,
Thyroglobulin Ab,  TPO Ab, TSH.

[u]Tumor Markers and Special Chemistry[/u]

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),
Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,
PAP, PSA, Thyroglobulin, Vitamin B-12.

[u]Immunoproteins[/u]

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,
Immunofixation, Prealbumin, Protein Electrophoresis.

[u]Drugs of Abuse [/u]

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,
LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),
Propoxyphene, Tricyclic Antidepressants.

Current and Emerging Products

- Analysis of current and emerging clinical chemistry
and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison
of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging
technologies, and their potential  market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D. 

- The companies analyzed in the report include: 

   – Abbott Laboratories
   – AdnaGen
   – Agilent Technologies          [u]
[/u]
   – Beckman Coulter/Danaher
   – Biomedical Diagnostics
   – BioMerieux
   – Bio-Rad              [u]
[/u]
   – DiaSorin
   – Eiken
   – Fujirebio/Innogenetics
   – Instrumentation Laboratory
   – Kyowa Medex
   – Matritech/Alere
   – Ortho-Clinical Diagnostics
   – Quest Diagnostics
   – Roche
   – Siemens
   – Sysmex
   – Thermo Fisher
   – Tosoh
   – Wako
   – Wallac/PE

Contains 559 pages and 103 tables

*** レポート目次(コンテンツ)***

※目次は下記のURLでご確認ください。

http://www.vpgcorp.com/webfiles/CC/TOCLOTNewFrontiersintheJapaneseCCandImmunodiagnosticMarketsBusinessChallengesEmergingTechCompetitiveLandscape.pdf



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • メタミトロン-デスアミノの世界市場2018
    Metamitron-Desamino Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Ge …
  • 世界のCNCスピンドル市場2016
    Notes:Production, means the output of CNC Spindle Revenue, means the sales value of CNC Spindle This report studies CNC Spindle in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenu …
  • 日焼け後のケア用品の世界市場2018-2022
    About After Sunburn Care Products After sunburn care products refer to the products used to relieve sunburn caused due to prolonged exposure to the sun. Technavio’s analysts forecast the Global After Sunburn Care Products Market to grow at a CAGR of 3.89% during the period 2018-2022. [Covered in thi …
  • 世界のキャノーラ油市場2016
    Notes: Production, means the output of Canola Oil Revenue, means the sales value of Canola Oil This report studies Canola Oil in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price …
  • アジア先進国の通信市場:中間予測アップデート2014–2019
    The Developed Asia–Pacific (DVAP) region is an early adopter of technology and smartphone and LTE adoption is already high. By 2019, smartphones and LTE will account for 95% and 80% of handsets and mobile connections (excluding M2M) respectively. This report provides an interim update of our forecas …
  • 院外における細菌感染性肺炎(Community-Acquired Bacterial Pneumonia):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)
    DelveInsight’s, “Community-Acquired Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Community-Acquired Bacterial Pneumonia. A key objective of DelveInsight …
  • エジプトのプラスチック製バスルーム用製品市場(~2019):市場規模、動向、予測
    The report Plastic Bathroom Ware Market in Egypt to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for plastic monofilaments and rods (over 1 mm) in Egypt. The research includes historic data from 2008 to 201 …
  • アメリカの貯蓄銀行市場
    Savings Banks (Savings Associations, Savings and Loans) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 522120 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hou …
  • 音楽ストリーミングサービスの世界市場2018-2022
    About Music Streaming Service Music streaming is a service that allows consumers to stream and listen to music using a device connected to the internet. Technavio’s analysts forecast the Global Music Streaming Service Market to grow at a CAGR of 16.77% during the period 2018-2022. Covered in this re …
  • 南米のヘルニア修復術(医療機器)市場分析・予測
    Hernia Repair - South American Analysis and Market Forecasts Summary Hernia is a term used to describe the protrusion of an internal organ or tissue through a weak portion of a muscle or connective tissue. The majority of hernias occur in the abdomen, where they are caused by a combination of increa …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(VPCC8135 )"日本の臨床化学・免疫診断市場" (英文:New Frontiers in the Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape)はVenture Planning Group社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。